Sava Infond d.o.o. Invests $275,000 in Colgate-Palmolive Company $CL

Sava Infond d.o.o. bought a new position in shares of Colgate-Palmolive Company (NYSE:CL) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 3,020 shares of the company’s stock, valued at approximately $275,000.

A number of other institutional investors have also made changes to their positions in the company. LGT Fund Management Co Ltd. lifted its position in shares of Colgate-Palmolive by 13.6% during the second quarter. LGT Fund Management Co Ltd. now owns 36,720 shares of the company’s stock worth $3,338,000 after purchasing an additional 4,391 shares in the last quarter. Quent Capital LLC lifted its position in shares of Colgate-Palmolive by 5.9% during the second quarter. Quent Capital LLC now owns 4,452 shares of the company’s stock worth $405,000 after purchasing an additional 247 shares in the last quarter. Wallington Asset Management LLC lifted its position in shares of Colgate-Palmolive by 0.3% during the second quarter. Wallington Asset Management LLC now owns 71,675 shares of the company’s stock worth $6,515,000 after purchasing an additional 180 shares in the last quarter. Ascent Group LLC lifted its position in shares of Colgate-Palmolive by 19.7% during the second quarter. Ascent Group LLC now owns 25,512 shares of the company’s stock worth $2,319,000 after purchasing an additional 4,195 shares in the last quarter. Finally, Barrett & Company Inc. lifted its position in shares of Colgate-Palmolive by 617.3% during the second quarter. Barrett & Company Inc. now owns 2,152 shares of the company’s stock worth $196,000 after purchasing an additional 1,852 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Down 0.4%

CL stock opened at $78.01 on Friday. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. Colgate-Palmolive Company has a 1-year low of $77.91 and a 1-year high of $102.61. The firm has a fifty day moving average price of $83.29 and a two-hundred day moving average price of $88.33. The firm has a market cap of $63.05 billion, a price-to-earnings ratio of 21.91, a PEG ratio of 4.07 and a beta of 0.34.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. During the same quarter in the previous year, the firm earned $0.91 earnings per share. The firm’s revenue for the quarter was up 1.0% compared to the same quarter last year. Research analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be paid a dividend of $0.52 per share. The ex-dividend date is Friday, October 17th. This represents a $2.08 annualized dividend and a yield of 2.7%. Colgate-Palmolive’s payout ratio is presently 58.43%.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Barclays reduced their target price on shares of Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating on the stock in a research report on Wednesday. UBS Group dropped their price target on shares of Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating for the company in a research note on Thursday, July 17th. The Goldman Sachs Group dropped their price target on shares of Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating for the company in a research note on Thursday. Wells Fargo & Company dropped their price target on shares of Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating for the company in a research note on Thursday, September 25th. Finally, JPMorgan Chase & Co. dropped their price target on shares of Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating for the company in a research note on Monday, August 4th. Seven investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Colgate-Palmolive has a consensus rating of “Hold” and a consensus price target of $94.83.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.